Diabetic Macular Edema in Underrepresented Populations
Elevatum-ML43435 (Sponsor: Genetech)
2022-Present
Office: Teaneck
NCT Number: NCT05224102
This Phase 4 study is designed to investigate treatment response in treatment-naïve underrepresented patients with diabetic macular edema (DME) who are treated with faricimab. The study population will consist of participants ≥18 years of age who self-identify as Black/African American, Hispanic/Latino American, or Native American/Alaska Native/Native Hawaiian or other Pacific Islander.
For more information, click here.
Retinal Vein Occlusion
Quasar – 22153
2023-Present
Office: Teaneck
NCT Number: NCT05850520
This Phase 3 study is designed to investigate treatment response to high-dose aflibercept (8 mg) vs standard of care (2 mg) in patients with macular edema secondary to retinal vein occlusion via intravitreal (IVT) injections. If the patients’ sight improves, marked by Best Corrected Visual Acuity (BCVA), the intervals of IVT injections will increase as well.
For more information, click here.
Geographic Atrophy
Concerto- CDV-SNG-21-001 (Sponsor: Samsara)
In Conjunction with Dr. Miller
2022-Present
Office: Teaneck
NCT Number: NCT05438732
The objective of this study is to determine the safety and effectiveness of the smaller incision, new generation (SING), implantable miniature telescope (IMT) in patients with moderate-severe central vision loss due to late-stage age-related macular degeneration (AMD). Following completion of informed consent, patients will be evaluated for eligibility to enroll into the study, including assessment of their best-corrected distance- and near- visual acuity with and without refraction, and also when using an external telescope simulator (ETS) to determine if they are likely to benefit from receiving the IMT. If eligible, they will be scheduled for out-patient surgery to implant the IMT during routine cataract surgery. Following implantation, patients will return for 5 post-operative follow-up visits over a period of approximately 12 months. Additionally, patients will have up to 12 rehabilitation/training visits with a low vision specialist.
For more information, click here.